Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma

Area of Science:

• Hematology
• Oncology
• Nanomedicine

Background:

• Multiple myeloma (MM) is an incurable blood cancer with high relapse rates.
• Traditional chemotherapy for MM causes significant side effects and lacks targeted delivery.
• There is a need for more effective and safer MM treatment strategies.

Purpose of the Study:

• To review current nanoparticle-based strategies for treating multiple myeloma.
• To highlight the advantages of nanomedicine over traditional chemotherapy in MM treatment.
• To discuss various nanoparticle delivery systems investigated for MM.

Main Methods:

• Review of preclinical and clinical studies on nanoparticle delivery systems for MM.
• Categorization of nanoparticle systems into non-targeted, triggered, and targeted approaches.
• Analysis of targeting strategies including VLA-4, ABC drug transporters, and bone microenvironment targeting.

Main Results:

• Nanoparticle delivery systems demonstrate potential for targeted MM treatment.
• Various non-targeted (liposomes, polymeric, inorganic NPs) and targeted NPs show promise.
• Preclinical and clinical results indicate encouraging outcomes for nanomedicine in MM.

Conclusions:

• Nanoparticle-based strategies represent a significant advancement in multiple myeloma therapy.
• These systems can improve drug delivery, efficacy, and reduce systemic toxicity.
• Further research in nanomedicine is crucial for optimizing MM treatment.